Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Interaction of polycyclic aromatic hydrocarbons with human cytochrome P450 1B1 in inhibiting catalytic activity.

Shimada T, Murajama N, Tanaka K, Takenaka S, Imai Y, Hopkins NE, Foroozesh MK, Alworth WL, Yamazaki H, Guengerich FP, Komori M.

Chem Res Toxicol. 2008 Dec;21(12):2313-23.

2.

Satellite DNA hypomethylation in karyotyped Wilms tumors.

Ehrlich M, Hopkins NE, Jiang G, Dome JS, Yu MC, Woods CB, Tomlinson GE, Chintagumpala M, Champagne M, Dillerg L, Parham DM, Sawyer J.

Cancer Genet Cytogenet. 2003 Mar;141(2):97-105.

PMID:
12606126
3.

Differential expression of CYP102 in Bacillus megaterium by 17-beta-estradiol and 4-sec-butylphenol.

Rowley CW, Rajnarayanan RV, Hopkins NE, Alworth WL.

Biochem Biophys Res Commun. 2003 Jan 3;300(1):102-6.

PMID:
12480527
4.

Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.

Tsien F, Sun B, Hopkins NE, Vedanarayanan V, Figlewicz D, Winokur S, Ehrlich M.

Mol Genet Metab. 2001 Nov;74(3):322-31.

PMID:
11708861
5.

Regulation of phenobarbital-mediated induction of CYP102 (cytochrome P450(BM-3)) in Bacillus megaterium by phytochemicals from soy and green tea.

Rajnarayanan RV, Rowley CW, Hopkins NE, Alworth WL.

J Agric Food Chem. 2001 Oct;49(10):4930-6.

PMID:
11600046
6.
7.

Lipoid pneumonia: a silent complication of mineral oil aspiration.

Bandla HP, Davis SH, Hopkins NE.

Pediatrics. 1999 Feb;103(2):E19.

PMID:
9925865
8.

Catalytic properties of an expressed cytochrome P450 2B1 from a Wistar-Kyoto rat liver cDNA library.

Kobayashi Y, Strobel SM, Hopkins NE, Alworth WL, Halpert JR.

Drug Metab Dispos. 1998 Oct;26(10):1026-30.

PMID:
9763409
9.

Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1.

Shimada T, Yamazaki H, Foroozesh M, Hopkins NE, Alworth WL, Guengerich FP.

Chem Res Toxicol. 1998 Sep;11(9):1048-56.

PMID:
9760279
10.

Induction of CYP102 (cytochrome P450BM-3) in Bacillus megaterium by 17 beta-estradiol and 4-sec-butylphenol.

Hopkins NE, English N, Hughes V, Rowley CW, Wolf CR, Alworth WL.

Biochem Biophys Res Commun. 1998 Mar 27;244(3):868-72. Erratum in: Biochem Biophys Res Commun 1998 May 29;246(3):933.

PMID:
9535758
11.

Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes.

Roberts ES, Hopkins NE, Foroozesh M, Alworth WL, Halpert JR, Hollenberg PF.

Drug Metab Dispos. 1997 Nov;25(11):1242-8.

PMID:
9351899
12.

Mechanistic studies of 9-ethynylphenanthrene-inactivated cytochrome P450 2B1.

Roberts ES, Ballou DP, Hopkins NE, Alworth WL, Hollenberg PF.

Arch Biochem Biophys. 1995 Nov 10;323(2):303-12.

PMID:
7487092
13.

Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthrene.

Roberts ES, Hopkins NE, Zaluzec EJ, Gage DA, Alworth WL, Hollenberg PF.

Arch Biochem Biophys. 1995 Nov 10;323(2):295-302.

PMID:
7487091
14.

Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.

Dreisbach AW, Ferencz N, Hopkins NE, Fuentes MG, Rege AB, George WJ, Lertora JJ.

Clin Pharmacol Ther. 1995 Nov;58(5):498-505.

PMID:
7586943
15.

Identification of active-site peptides from 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry.

Roberts ES, Hopkins NE, Zaluzec EJ, Gage DA, Alworth WL, Hollenberg PF.

Biochemistry. 1994 Mar 29;33(12):3766-71.

PMID:
8142377
16.

Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide.

Roberts ES, Hopkins NE, Alworth WL, Hollenberg PF.

Chem Res Toxicol. 1993 Jul-Aug;6(4):470-9.

PMID:
8374044
17.

Modification of cytochrome P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl.

Yun CH, Hammons GJ, Jones G, Martin MV, Hopkins NE, Alworth WL, Guengerich FP.

Biochemistry. 1992 Nov 3;31(43):10556-63.

PMID:
1420171
18.

Suicide inhibitors of cytochrome P450 1A1 and P450 2B1.

Hopkins NE, Foroozesh MK, Alworth WL.

Biochem Pharmacol. 1992 Aug 18;44(4):787-96.

PMID:
1510726
19.

Inhibition of the binding of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene to DNA in mouse skin epidermis by 1-ethynylpyrene.

Viaje A, Lu JY, Hopkins NE, Nettikumara AN, DiGiovanni J, Alworth WL, Slaga TJ.

Carcinogenesis. 1990 Jul;11(7):1139-43.

PMID:
2115405
20.

Effects of 1-ethynylpyrene and related inhibitors of P450 isozymes upon benzo[a]pyrene metabolism by liver microsomes.

Hall M, Parker DK, Grover PL, Lu JY, Hopkins NE, Alworth WL.

Chem Biol Interact. 1990;76(2):181-92.

PMID:
2225228
21.

2-ethynylnaphthalene as a mechanism-based inactivator of the cytochrome P-450 catalyzed N-oxidation of 2-naphthylamine.

Hammons GJ, Alworth WL, Hopkins NE, Guengerich FP, Kadlubar FF.

Chem Res Toxicol. 1989 Nov-Dec;2(6):367-74.

PMID:
2519725
22.

Effect of phenazopyridine hydrochloride ("Pyridium") on determination of ethchlorvynol ("Placidyl").

Cantrell JW, Hopkins NE, Queen CA, Frings CS.

Clin Chem. 1972 Jun;18(6):591-2. No abstract available.

PMID:
5026773

Supplemental Content

Loading ...
Support Center